The ingredient will be distributed exclusively in Australia by Trans Chem, a biotech specialist that sources and imports fine chemicals to Australian manufacturers. TGA approval of Setria glutathione was received in October, after a milestone clinical trial of the master antioxidant showed positive results, which were published in the European Journal of Nutrition. Setria meets the current United States Pharmacopeial (USP) Convention Standards and is available as a dietary supplement in the U.S., Canada, Mexico and select countries in Europe and Asia.
Glutathione is a potent and natural antioxidant. Kyowa Hakko uses a patented fermentation technology to manufacture a pure form of glutathione. Called nature’s “master antioxidant,” glutathione replenishes the body’s stores helping to protect cells from oxidative stress and harmful toxins associated with free radicals.